 <h1>Norepinephrine Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to norepinephrine: parenteral injection</i></p><h3>Warning</h3><p><ul>
Extravasation Risk
<li>
<i>Phentolamine</i> is the local antidote for peripheral ischemia resulting from extravasation of norepinephrine.&lt;sup&gt;101&lt;/sup&gt;</li></ul></p><ul>
Extravasation Risk
<li>
<i>Phentolamine</i> is the local antidote for peripheral ischemia resulting from extravasation of norepinephrine.&lt;sup&gt;101&lt;/sup&gt;</li></ul><p>
<li>
<i>Phentolamine should be given as soon as possible</i> after extravasation is noted.&lt;sup&gt;101&lt;/sup&gt;</li></p><p>
<li>
Infiltrate the affected area (using a syringe with a fine hypodermic needle) liberally throughout as soon as possible with 10–15 mL of 0.9% sodium chloride injection containing 5–10 mg of phentolamine mesylate (an α-adrenergic blocking agent) to prevent sloughing and necrosis in ischemic areas.&lt;sup&gt;101&lt;/sup&gt;</li></p><p>
<li>
Sympathetic blockade with phentolamine causes immediate and conspicuous local hyperemic changes if the area is infiltrated within 12 hours.&lt;sup&gt;101&lt;/sup&gt;</li></p><p></p><p>Side effects include:</p><p>May cause headache, anxiety, arrhythmias, bradycardia, respiratory difficulty, ischemic injury, or extravasation at the infusion site. </p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to norepinephrine: injectable solution, intravenous solution</i></p><h3>General</h3><p>If plasma volumes are not corrected, hypotension may recur when this drug is discontinued, or blood pressure may be maintained at the risk of severe peripheral and visceral vasoconstriction (e.g., decreased renal perfusion) with diminution in blood flow and tissue perfusion with subsequent tissue hypoxia and lactic acidosis and possible ischemic injury.  Overdoses or conventional doses in hypersensitive patients (e.g., hyperthyroid patients) can cause severe hypertension with violent headache, photophobia, stabbing retrosternal pain, pallor, intense sweating, and vomiting.<sup>[Ref]</sup></p><h3>Local</h3><p><b>Frequency not reported</b>: Extravasation necrosis<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Frequency not reported</b>: Ischemic injury, bradycardia, arrhythmia, blood pressure increased, hypertension, pallor, stabbing retrosternal pain<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Frequency not reported</b>: Headache</p><h3>Dermatologic</h3><p><b>Frequency not reported</b>: Sweating<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Frequency not reported</b>: Vomiting<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Photophobia<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Frequency not reported</b>: Plasma volume depletion<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Frequency not reported</b>: Anxiety<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Frequency not reported</b>: Respiratory difficulty, dyspnea</p><h3>Other</h3><p><b>Frequency not reported</b>: Gangrene<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Levophed (norepinephrine)." Hospira Inc, Lake Forest, IL. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>Norepinephrine vs epinephrine: what's the difference?</li>
<li>Strattera vs Adderall: What is the difference?</li>
<li>What are some common side effects of antidepressants?</li>
</ul><h2>More about norepinephrine</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Support Group</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>1 Review</li>
<li>Drug class: catecholamines</li>
<li>FDA Alerts (1)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Norepinephrine Intravenous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +3 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Shock</li>
<li>Hypotension</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>